Myomo (MYO) Operating Income (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 23.37% |
| Jun 30, 2025 | -30.40% |
| Mar 31, 2025 | -1,335.00% |
| Dec 31, 2024 | 74.38% |
| Sep 30, 2024 | 14.13% |
| Jun 30, 2024 | 71.33% |
| Mar 31, 2024 | -59.82% |
| Dec 31, 2023 | -20.19% |
| Sep 30, 2023 | -83.53% |
| Jun 30, 2023 | 58.70% |
| Mar 31, 2023 | -19.81% |
| Dec 31, 2022 | 20.91% |
| Sep 30, 2022 | 2.67% |
| Jun 30, 2022 | -5.74% |
| Mar 31, 2022 | -1.22% |
| Dec 31, 2021 | -33.27% |
| Sep 30, 2021 | 21.90% |
| Jun 30, 2021 | 11.35% |
| Mar 31, 2021 | -73.87% |
| Dec 31, 2020 | 33.73% |
| Sep 30, 2020 | 10.65% |
| Jun 30, 2020 | 16.77% |
| Mar 31, 2020 | -32.61% |
| Dec 31, 2019 | 8.65% |
| Sep 30, 2019 | -4.39% |
| Jun 30, 2019 | -0.88% |
| Mar 31, 2019 | 1.91% |
| Dec 31, 2018 | -0.98% |
| Sep 30, 2018 | -0.98% |
| Jun 30, 2018 | -11.62% |
| Mar 31, 2018 | -32.32% |
| Dec 31, 2017 | -26.55% |
| Sep 30, 2017 | 25.78% |
| Jun 30, 2017 | -41.78% |
| Mar 31, 2017 | -24.31% |
| Dec 31, 2016 | -17.47% |
| Sep 30, 2016 | -35.62% |